3 Stocks to Buy for a Volatile End to 2025

Amidst expectations of a volatile "Santa Claus Rally" driven by economic headwinds like rising layoffs and tech sector corrections, this analysis identifies three companies exhibiting strong insider buying and fundamental value. Utz Brands (UTZ) is presented as a consumer staple trading at a significant discount with cluster insider purchases, signaling resilience. Greenwich LifeSciences (GLSI), a biotech firm, shows CEO buying and regulatory tailwinds for its promising breast cancer drug, suggesting undervaluation despite short interest. Matador Resources (MTDR), an oil and gas producer, is highlighted for extensive insider buying, low-cost operations, and an attractive valuation, offering diversification from high-priced tech.

Analysis

The market anticipates a volatile 'Santa Claus Rally' in late 2025, driven by conflicting forces of traditional year-end boosts and significant economic headwinds. A weakening labor market, with over 150,000 October layoffs, and record-low consumer sentiment are contributing to uncertainty, evidenced by the Nasdaq's 5% decline and Amazon's (AMZN) 6% drop.

Amidst this volatility, Utz Brands (UTZ) appears deeply undervalued, trading at 13x forward earnings, half its long-term average, after a 34% stock decline. Significant 'cluster buying' by its top management following a post-earnings selloff signals strong internal confidence in its defensive resilience and consistent market share growth.

Greenwich LifeSciences (GLSI) exhibits strong insider conviction, with its CEO purchasing shares after a 33% decline driven by short selling. The biotech firm has secured FDA Fast Track designation and European approval for its Phase III breast cancer drug, which demonstrated an 80% recurrence reduction, suggesting undervaluation and potential for acquisition.

Matador Resources (MTDR) offers diversification and value, with extensive insider buying from 12 directors and managers. This oil and gas producer maintains an attractive cost structure and trades at an industry-low 0.81x book value and 6.3x forward earnings, making it an appealing alternative as institutional cash pivots to safer, dividend-paying assets.

Key Decisions for Investors

• Investors should consider defensive consumer staples like Utz Brands (UTZ) due to its deep valuation discount, consistent market share growth, and strong insider buying, offering resilience amidst market volatility.
• Evaluate Greenwich LifeSciences (GLSI) for its CEO's recent share purchase, critical regulatory advancements, and promising clinical data, which suggest significant upside potential despite short-term pressures.
• Diversify portfolios with value-oriented energy exposure through Matador Resources (MTDR), given its extensive insider confidence, low-cost operations, discounted valuation, and attractive dividend yield in a volatile market.